Meniere's disease treatment may reduce recurrence of low-frequency sudden sensorineural hearing loss

Not Applicable

Recruiting

• Conditions: Diseases of the ear and mastoid process

• Registration Number: KCT0006639
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Unilateral hearing loss, tinnitus, and dullness that occurred suddenly within 2 weeks before the start of the initial treatment.
- When the airway threshold of the pure tone hearing test is 30dB or higher at 250 or 500 Hz and less than 30dB at 1, 2, or 4 kHz
- Patients who have completed initial treatment (steroids)

Exclusion Criteria

- When rotational dizziness persists for more than 20 minutes with the onset of auditory symptoms
- When the contralateral hearing is 25dB or higher (standard of normal hearing suggested by WHO), the average airway threshold of pure tone audiometry (average threshold of 0.5, 1, 2, 4 kHz)
- If there is conductive hearing loss in pure tone audiometry or if there is a lesion in the eardrum and middle ear on otoscopy
- If there is a cause that may cause hearing loss within 1 month of onset. (Example: exposure to noise, anticancer drugs, antibiotics)
- taking or need to take steroids, betahistine, or diuretics for other diseases

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
recurrence rate

Secondary Outcome Measures

Name	Time	Method
earfullness;dizziness